Workflow
Lucky Film Co.,Ltd.(600135)
icon
Search documents
乐凯胶片:乐凯胶片股份有限公司主要经营数据
2024-04-24 12:54
一、2024 年第一季度主要产品经营情况 | 产品名称 | 单位 | 产量 | 销量 | 销售收入 (人民币万元) | | --- | --- | --- | --- | --- | | 银盐产品 | | | | | | 彩色相纸 | 万平米 | 952.86 | 952.94 | 10,837.50 | | 光伏产品 | | | | | | 太阳能背板 | 万平米 | 461.07 | 816.57 | 5,816.78 | | 医疗产品 | | | | | | 医用干式胶片 | 万平米 | 436.88 | 419.07 | 7,084.90 | | 光电产品 | | | | | | 膜 TAC | 万平米 | 387.55 | 413.09 | 5,545.25 | 证券代码:600135 证券简称:乐凯胶片 公告编号:2024-024 乐凯胶片股份有限公司 2024 年第一季度主要经营数据 本公司及董事会全体成员保证公告内容的真实、准确和完整,对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 乐凯胶片股份有限公司(以下简称"本公司")根据《上海证券交易所上市公 司自律监管指引第 3 号——行业信 ...
乐凯胶片(600135) - 2024 Q1 - 季度财报
2024-04-24 09:41
Financial Performance - The company's operating revenue for Q1 2024 was ¥353,923,072.11, a decrease of 35.84% compared to ¥492,634,295.49 in the same period last year[6] - The net profit attributable to shareholders was -¥19,664,836.10, representing a decline of 453.67% from a profit of ¥1,108,180.87 in the previous year[6] - Basic and diluted earnings per share were both -¥0.0400, a decrease of 500.00% compared to ¥0.0020 in Q1 2023[7] - In Q1 2024, the company reported a net loss of ¥19,228,029.85, compared to a net profit of ¥6,026,292.60 in Q1 2023, indicating a significant decline in profitability[21] - Operating profit for Q1 2024 was -¥17,940,790.90, a decrease from an operating profit of ¥9,456,801.31 in the same period last year[21] - Total revenue from operating activities was ¥272,310,244.56, down from ¥355,622,311.06 in Q1 2023, reflecting a decrease of approximately 23.4%[24] - The company reported a total comprehensive loss of ¥19,228,029.85 for Q1 2024, compared to a comprehensive income of ¥6,026,292.60 in Q1 2023, marking a substantial decline in overall financial health[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,071,473,699.68, down 14.32% from ¥3,585,000,723.93 at the end of the previous year[7] - The company's cash and cash equivalents decreased to RMB 466,837,916.51 from RMB 1,358,664,189.37, a decline of 65.6%[15] - Total assets as of March 31, 2024, were RMB 3,071,473,699.68, down from RMB 3,585,000,723.93 at the end of 2023, representing a decrease of 14.3%[17] - Total liabilities decreased to RMB 575,071,527.75 from RMB 1,069,370,522.15, a reduction of 46.2%[18] - The total equity attributable to shareholders decreased to RMB 2,474,696,899.95 from RMB 2,494,361,736.05, a decline of 0.8%[18] Cash Flow - The company reported a net cash flow from operating activities of -¥146,997,078.73, a significant decline compared to -¥34,342,098.21 in the same period last year[7] - The company experienced a net cash outflow from operating activities of -¥146,997,078.73 in Q1 2024, compared to -¥55,339,380.75 in Q1 2023, indicating worsening cash flow issues[25] - Investment activities resulted in a net cash outflow of -¥673,663,710.66 in Q1 2024, compared to -¥309,662,209.35 in Q1 2023, highlighting increased investment expenditures[25] Operating Costs - The company experienced a 34.14% decrease in operating costs, primarily due to reduced sales volume[10] - Total operating costs for Q1 2024 were RMB 376,831,657.85, down from RMB 548,924,130.78 in Q1 2023, reflecting a reduction of 31.2%[20] - Management expenses decreased to ¥29,731,891.55 in Q1 2024 from ¥31,882,746.48 in Q1 2023, showing a reduction in operational costs[21] - Research and development expenses were ¥22,330,133.16 in Q1 2024, down from ¥28,906,443.26 in Q1 2023, indicating a cutback in R&D investment[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 27,660[13] - The company's inventory stood at RMB 420,875,038.05, slightly down from RMB 426,868,401.96, indicating a decrease of 1.4%[16] - The company reported a decrease in accounts receivable to RMB 260,122,482.02 from RMB 168,343,801.81, an increase of 54.5%[16] Strategic Developments - The company completed the acquisition of 100% equity in LeKai Optoelectronic Materials Co., Ltd. in 2023, leading to adjustments in the consolidated financial statements[7] - The company has not reported any significant new product developments or market expansions during this quarter[19]
乐凯胶片:北京市兰台律师事务所关于乐凯胶片股份有限公司2023年年度股东大会的法律意见书
2024-04-24 09:41
北京市兰台律师事务所 关于乐凯胶片股份有限公司 2023 年年度股东大会的 法律意见书 地址:北京市朝阳区曙光西里甲1号第三置业B座29层 电话:(8610)52287799 传真:(8610)58220039 邮编:100028 网址:www.lantai.cn 法律意见书 北京市兰台律师事务所 关于乐凯胶片股份有限公司 2023年年度股东大会的 法律意见书 兰台意字(2024)第 1435 号 致:乐凯胶片股份有限公司 北京市兰台律师事务所(以下简称"本所")接受乐凯胶片股份有限公司(以 下简称"公司")的委托,指派王成宪律师、曹文文律师见证公司 2023 年年度 股东大会(以下简称"本次股东大会"或"会议")。现依据《中华人民共和国 公司法》(以下简称"《公司法》")、《上市公司股东大会规则》(以下简称 "《股东大会规则》")等法律、行政法规、规范性文件及《乐凯胶片股份有限 公司章程》(以下简称"《公司章程》")的规定,本所律师就本次股东大会的 相关事项进行验证并出具本法律意见书。 对于出具本法律意见书,本所特做如下声明: 1.为出具本法律意见书,本所律师审查了公司提供的有关本次股东大会的文 件,同时听 ...
乐凯胶片:乐凯胶片股份有限公司董事、监事及高级管理人员关于2024年第一季度报告的书面确认意见
2024-04-24 09:41
| 王洪泽 | 路建波 | 张永光 | | --- | --- | --- | | 李保民 | 宋文胜 | 谢敏 | | 张双才 | 曹宇 | 文新祥 | | 徐志会 | 汪玉婷 | 丁伟 | | 张静 | 观趁 | 张伦 | | 朱志广 | 陈焱 | | 乐凯胶片股份有限公司 2024 年 4 月 24 日 乐凯胶片股份有限公司董事、监事及高级管理人员 关于 2024 年第一季度报告的书面确认意见 根据《证券法》第 82 条的规定和上海证券交易所关于上市公司 2024 年第 一季度报告报送文件的有关要求,我们作为公司的董事、监事和高级管理人员, 在全面了解和审核公司 2024 年第一季度报告后,认为:公司能够严格按照股份 制公司财务制度规范运作,公司 2024 年第一季度报告公允地反映了公司本报告 期的财务状况和经营成果;我们保证公司 2024 年第一季度报告所披露的信息是 真实、准确和完整的,我们承诺其中不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 (此页无正文,为公司董事、监事及高级管理人员关于 2024 年第一季度报告的 书面确认意见之签字页) ...
乐凯胶片:乐凯胶片股份有限公司2023年年度股东大会决议公告
2024-04-24 09:41
证券代码:600135 证券简称:乐凯胶片 公告编号:2024-023 乐凯胶片股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 (一)股东大会召开的时间:2024 年 4 月 24 日 (二)股东大会召开的地点:公司办公楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: | 1、出席会议的股东和代理人人数 | 13 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 268,050,237 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 48.4451 | | 份总数的比例(%) | | (四)表决方式是否符合《公司法》及《公司章程》的规定,大会主持情况等。 | | 同意 | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | | 股东类型 | 票数 | 比例 | ...
乐凯胶片:乐凯胶片股份有限公司关于使用闲置募集资金进行现金管理的进展公告
2024-04-23 11:43
证券代码:600135 证券简称:乐凯胶片 公告编号:2024-022 关于使用闲置募集资金进行现金管理的进展公告 公司及董事会全体成员保证公告内容的真实、准确和完整,对公告的虚假记载、 误导性陈述或者重大遗漏负连带责任。 重要内容提示: 一、本次使用暂时闲置募集资金购买现金管理产品概况 (一)现金管理目的 为了提高公司资金使用效率,最大限度地发挥暂时闲置募集资金的作用,在不 影响正常经营及风险可控的前提下,公司使用暂时闲置募集资金购买有保本约定的 现金管理产品。 (二)资金来源 1.资金来源的一般情况 全部为暂时闲置募集资金。 乐凯胶片股份有限公司 2.闲置募集资金构成情况 公司进行现金管理使用的闲置募集资金来源由两部分构成,一部分是公司 2014 年非公开发行股票募集资金的暂时闲置部分,另一部分为公司 2018 年发行股份购买 现金管理受托方:中国民生银行股份有限公司保定分行 本次现金管理金额:人民币 1,650 万元 现金管理产品名称:聚赢汇率-挂钩欧元对美元汇率结构性存款 现金管理期限:2024 年 4 月 24 日至 2024 年 7 月 23 日 履行的审议程序:第九届董事会第十三次会议 资产并募 ...
乐凯胶片:乐凯胶片股份有限公司关于使用闲置募集资金进行现金管理的进展公告
2024-04-19 08:34
证券代码:600135 证券简称:乐凯胶片 公告编号:2024-021 乐凯胶片股份有限公司 关于使用闲置募集资金进行现金管理的进展公告 公司及董事会全体成员保证公告内容的真实、准确和完整,对公告的虚假记载、 误导性陈述或者重大遗漏负连带责任。 重要内容提示: 一、本次使用暂时闲置募集资金购买现金管理产品概况 (一)现金管理目的 为了提高公司资金使用效率,最大限度地发挥暂时闲置募集资金的作用,在不 影响正常经营及风险可控的前提下,公司使用暂时闲置募集资金购买有保本约定的 现金管理产品。 2.闲置募集资金构成情况 (二)资金来源 1.资金来源的一般情况 公司进行现金管理使用的闲置募集资金来源由两部分构成,一部分是公司 2014 年非公开发行股票募集资金的暂时闲置部分,另一部分为公司 2018 年发行股份购买 现金管理受托方:中国建设银行股份有限公司保定分行 本次现金管理金额:人民币 3,000 万元 现金管理产品名称:中国建设银行河北省分行单位人民币定制型结构性存款 现金管理期限:2024 年 4 月 23 日至 2024 年 5 月 23 日 履行的审议程序:第九届董事会第十三次会议 全部为暂时闲置募集资金。 ...
乐凯胶片:乐凯胶片股份有限公司2023年年度股东大会会议资料
2024-04-17 08:41
乐凯胶片股份有限公司 2023 年年度股东大会 会议资料 2024 年 4 月 二、股东大会期间,全体出席人员应以维护股东的合法权益,确保大会正常 秩序和议事效率为原则,认真履行法定职责。 | | 股东大会会议须知 2 | | --- | --- | | | 股东大会会议议程 3 | | 会 | 议 议 案 5 | | (一) 公司2024 | 年经营方针的议案 6 | | (二) 公司2023 | 年年度财务决算报告的议案 7 | | (三) 公司2024 | 年年度财务预算方案的议案 8 | | (四) 公司2023 | 年年度利润分配预案的议案 9 | | (五) 公司2023 | 年年度报告及其摘要的议案 10 | | (六) 公司董事会2023 | 年年度工作报告的议案 11 | | (七) 公司监事会2023 | 年年度工作报告的议案 19 | | | 股东大会表决办法说明 22 | 乐凯胶片股份有限公司 2023 年年度股东大会会议资料 股东大会会议须知 根据中国证券监督管理委员会关于《上市公司股东大会规则》通知的有关规 定,为确保公司股东大会顺利进行,特制定大会须知如下,请出席股东大会的全 体 ...
乐凯胶片:乐凯胶片股份有限公司关于使用闲置募集资金进行现金管理到期赎回的公告
2024-04-16 07:37
证券代码:600135 证券简称:乐凯胶片 公告编号:2024-020 乐凯胶片股份有限公司 关于使用闲置募集资金进行现金管理 到期赎回的公告 公司及董事会全体成员保证公告内容的真实、准确和完整,对公告的虚假记载、 误导性陈述或者重大遗漏负连带责任。 | 序 | | | 产品 | 产品 | 年化 | 赎回 | 实际 | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | 受托方及产品名称 | 金额 | 期限 | 收益率 | 金额 | 收益 | | | | | (万元) | (日) | (%) | (万元) | (万元) | | 1 | 受托方 | 中国银行股份有限公司保 | 4,500 | 31 | 2.48 | 4500 | 9.50 | | | 名称 | 定分行 | | | | | | | | 产品名 | 挂钩型结构性存款(机构客 | | | | | | | | 称 | 户) | | | | | | 具体情况如下: 二、截至 2024 年 4 月 16 日,公司最近十二个月使用募集资金现金管理的情况 单位:万元 | 序号 | 现金管理产品类型 ...
乐凯胶片(600135) - 2023 Q4 - 年度财报
2024-03-28 16:00
Financial Performance - In 2023, the company's operating revenue was CNY 2,117,635,489.53, a decrease of 2.90% compared to CNY 2,180,913,231.81 in 2022[24]. - The net profit attributable to shareholders was a loss of CNY 46,661,313.73, representing a decline of 177.33% from a profit of CNY 60,341,393.44 in the previous year[24]. - The basic earnings per share for 2023 was -0.0843 CNY, down 177.27% from 0.1091 CNY in 2022[25]. - The company reported a net cash flow from operating activities of CNY 150,922,414.98, a decrease of 22.98% from CNY 195,959,629.81 in 2022[24]. - Total assets at the end of 2023 were CNY 3,585,000,723.93, down 4.98% from CNY 3,773,065,133.96 at the end of 2022[24]. - The net assets attributable to shareholders at the end of 2023 were CNY 2,494,361,736.05, a decrease of 13.40% from CNY 2,880,240,746.80 at the end of 2022[24]. - The company achieved operating revenue of 2.118 billion RMB, a decrease of 2.90% year-on-year, with main business revenue at 2.072 billion RMB, down 3.16%[49]. - The total profit was a loss of 39.24 million RMB, with net profit at a loss of 44.60 million RMB, representing a decline of 171.24% compared to the previous year[50]. Acquisitions and Investments - The company completed the acquisition of 100% equity in Lucky Optoelectronic Materials Co., Ltd., which adjusted the scope of the consolidated financial statements for 2023[25]. - The company completed the acquisition of 100% equity in LeKai Optoelectronic Materials Co., Ltd., which led to adjustments in the consolidated financial statements for 2023[28]. - The company plans to acquire 100% equity of LeKai Optoelectronic Materials Co., Ltd., with part of the raised funds being redirected for this transaction[135]. - The company completed the acquisition of 100% equity in LeKai Optoelectronics, making it a wholly-owned subsidiary, enhancing its layout in the optoelectronic display materials industry[58]. Market Dynamics - In 2023, the company's total revenue for the first three quarters was approximately CNY 1.66 billion, with a notable decline in Q4 revenue to CNY 451.14 million, representing a decrease of 19.5% compared to Q3[27]. - The net profit attributable to shareholders for Q3 was CNY 90.83 thousand, but it turned negative in Q4 with a loss of CNY 62.57 million, indicating a significant downturn in profitability[27]. - Domestic revenue decreased by 5.87% to 1.684 billion RMB, while international revenue increased by 10.73% to 387.99 million RMB, showing a shift in market dynamics[53]. - The company has expanded its market presence, exporting products to over 30 countries and regions, including Asia, Africa, and Latin America[79]. Research and Development - Research and development expenses increased by 5.89% to 118.42 million RMB, indicating a commitment to innovation despite overall revenue decline[50]. - The company has initiated over 40 R&D projects in the past three years, resulting in 14 patent applications, with 11 patents granted, including 5 invention patents[80]. - The company’s R&D projects include the development of medical dry film, classified as a Class I medical device, aimed at diagnostic imaging[82]. - The company employed 140 R&D personnel, accounting for 5% of the total workforce[65]. Operational Efficiency - The company achieved a 231% completion rate for its annual cost reduction plan through technological innovation[36]. - The company has optimized its production process in the lithium battery new energy business, leading to a steady improvement in the quality of base film products[37]. - The company has implemented nine environmental management plans to meet environmental management objectives and reduce emissions[39]. - The company has enhanced its financial management and risk management capabilities, leading to improved audit value and service capacity[39]. Customer Engagement and Marketing - The company focused on enhancing customer loyalty through equipment upgrades and targeted marketing strategies in the medical dry film and photovoltaic sectors[35]. - The company aims to enhance its market competitiveness by focusing on market demand and technological innovation, transitioning from a manufacturing to a high-tech service enterprise[80]. - The company plans to strengthen its marketing channels and enhance communication efficiency with downstream customers in the optical business[125]. Governance and Compliance - The company has established a robust internal control system to manage operational risks associated with hazardous materials and equipment[129]. - The company ensures timely and accurate information disclosure to maintain transparency and protect shareholder rights[133]. - The company has committed to complying with all relevant laws and regulations, ensuring transparency and accountability in its operations[180]. - The company has established a framework for fair and reasonable pricing in related party transactions, adhering to market principles[180]. Environmental Responsibility - The company invested 3.764 million yuan in environmental protection during the reporting period[169]. - The company has a silver recovery system with a processing capacity of 750 tons per day and a comprehensive wastewater treatment system with a capacity of 1,750 tons per day[171]. - The company has implemented low-nitrogen transformation for boilers to reduce nitrogen oxide emissions[173]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[172].